(Q45743836)

15 December 2017

title

Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus (English)

1 reference

15 December 2017

main subject

foot-and-mouth disease

1 reference

vaccinia virus

1 reference

foot-and-mouth disease virus

inferred from title

object named as

foot-and-mouth disease virus

1 reference

Berinstein A

1

1 reference

15 December 2017

Tami C

2

1 reference

15 December 2017

Taboga O

3

1 reference

15 December 2017

Smitsaart E

4

1 reference

15 December 2017

Carrillo E

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

issue

21

1 reference

15 December 2017

page(s)

2231-2238

1 reference

15 December 2017

Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

The structure and antigenicity of a type C foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Selection of recombinant vaccinia viruses on the basis of plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Role of cell-associated enveloped vaccinia virus in cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Reconstitution of immunosuppressed mice with mononuclear cells from donors sensitized to foot-and- mouth disease virus (FMDV)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Foot-and-mouth disease virus (FMDV) experimental infection: susceptibility and immune response of adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Protein of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Isotype profiles induced in Balb/c mice during foot and mouth disease (FMD) virus infection or immunization with different FMD vaccine formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Protection of cattle against foot-and-mouth disease by a synthetic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Serological response of guinea pigs to inactivated 146S antigens of foot and mouth disease virus after single or repeated inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

Homologous and heterologous antibody response of cattle and sheep after vaccination with foot and mouth disease and influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900561-7

7 January 2021

10.1016/S0264-410X(99)00561-7

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017